CAMBRIDGE, Mass.--(BUSINESS WIRE)--Paragonix Technologies Inc., today announced appointment of Leonard A. R. Golding, MB, BS, FRACS, FRCS(C), FACC, to the position of Chief Medical Officer. Dr. Golding will be responsible for all clinical development activities related to the Paragonix Sherpa™ Cardiac Transport System1,2. Dr. Golding will also immediately assume the position of Chairman for the Paragonix Clinical Advisory Board (CAB). The CAB will meet periodically to assess the development strategies for Paragonix Sherpa™ and advise the company on the state of the cardiac transplantation market. Lisa Maier, PhD, Chief Operating Officer and Co-Founder for Paragonix commented, “We are thrilled to have Dr. Golding join the Paragonix team as Chief Medical Officer. With experience spanning both cardiac surgery as well as mechanical circulatory support development, Dr. Golding is uniquely suited to advance our development activities as the Paragonix Sherpa™ Cardiac Transport System is prepared for entering the market. We look forward to his contribution as a member of the Paragonix team.”
